• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中tau 沉积的四种不同轨迹。

Four distinct trajectories of tau deposition identified in Alzheimer's disease.

机构信息

Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

出版信息

Nat Med. 2021 May;27(5):871-881. doi: 10.1038/s41591-021-01309-6. Epub 2021 Apr 29.

DOI:10.1038/s41591-021-01309-6
PMID:33927414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8686688/
Abstract

Alzheimer's disease (AD) is characterized by the spread of tau pathology throughout the cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, although recent work has demonstrated substantial variability in the population with AD. Using tau-positron emission tomography scans from 1,612 individuals, we identified 4 distinct spatiotemporal trajectories of tau pathology, ranging in prevalence from 18 to 33%. We replicated previously described limbic-predominant and medial temporal lobe-sparing patterns, while also discovering posterior and lateral temporal patterns resembling atypical clinical variants of AD. These 'subtypes' were stable during longitudinal follow-up and were replicated in a separate sample using a different radiotracer. The subtypes presented with distinct demographic and cognitive profiles and differing longitudinal outcomes. Additionally, network diffusion models implied that pathology originates and spreads through distinct corticolimbic networks in the different subtypes. Together, our results suggest that variation in tau pathology is common and systematic, perhaps warranting a re-examination of the notion of 'typical AD' and a revisiting of tau pathological staging.

摘要

阿尔茨海默病(AD)的特征是 tau 病理学在大脑皮层中的扩散。尽管最近的研究表明 AD 患者群体中存在很大的变异性,但这种扩散模式被认为在个体之间相当一致。我们使用来自 1612 个人的 tau 正电子发射断层扫描(PET)扫描,确定了 4 种不同的 tau 病理学时空轨迹,其患病率从 18%到 33%不等。我们复制了先前描述的以边缘系统为主和内侧颞叶保留的模式,同时还发现了类似于 AD 非典型临床变异的后部和外侧颞叶模式。这些“亚型”在纵向随访期间保持稳定,并在使用不同示踪剂的另一组样本中得到了复制。这些亚型表现出不同的人口统计学和认知特征,以及不同的纵向结局。此外,网络扩散模型表明,不同亚型中的病理起源和扩散通过不同的皮质边缘网络进行。总的来说,我们的研究结果表明,tau 病理学的变异性是常见的和系统的,这可能需要重新审视“典型 AD”的概念,并重新考虑 tau 病理分期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/0c25ec1bf58c/nihms-1760467-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/31fd8b1e8a2f/nihms-1760467-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/9eaee64bf660/nihms-1760467-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/f722108ca235/nihms-1760467-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/76bb738566d1/nihms-1760467-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/2d88b2cd85fa/nihms-1760467-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/31c930f53977/nihms-1760467-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/c67ab33b4f92/nihms-1760467-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/f95f23606e37/nihms-1760467-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/5a25f748f078/nihms-1760467-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/7572403ed9d2/nihms-1760467-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/6479d83f3a7a/nihms-1760467-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/a8a11ee1053e/nihms-1760467-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/0203bbb91925/nihms-1760467-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/dd6789f46bbc/nihms-1760467-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/0c25ec1bf58c/nihms-1760467-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/31fd8b1e8a2f/nihms-1760467-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/9eaee64bf660/nihms-1760467-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/f722108ca235/nihms-1760467-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/76bb738566d1/nihms-1760467-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/2d88b2cd85fa/nihms-1760467-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/31c930f53977/nihms-1760467-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/c67ab33b4f92/nihms-1760467-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/f95f23606e37/nihms-1760467-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/5a25f748f078/nihms-1760467-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/7572403ed9d2/nihms-1760467-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/6479d83f3a7a/nihms-1760467-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/a8a11ee1053e/nihms-1760467-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/0203bbb91925/nihms-1760467-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/dd6789f46bbc/nihms-1760467-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49b/8686688/0c25ec1bf58c/nihms-1760467-f0005.jpg

相似文献

1
Four distinct trajectories of tau deposition identified in Alzheimer's disease.阿尔茨海默病中tau 沉积的四种不同轨迹。
Nat Med. 2021 May;27(5):871-881. doi: 10.1038/s41591-021-01309-6. Epub 2021 Apr 29.
2
Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.纵向神经影像学生物标志物在不同阿尔茨海默病表型中存在差异。
Brain. 2020 Jul 1;143(7):2281-2294. doi: 10.1093/brain/awaa155.
3
Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.阿尔茨海默病萎缩定义亚型中不同的 tau PET 模式。
Alzheimers Dement. 2020 Feb;16(2):335-344. doi: 10.1016/j.jalz.2019.08.201. Epub 2020 Jan 4.
4
Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging.使用氟替卡滨 PET 成像在体内确定阿尔茨海默病的 Tau 亚型。
J Alzheimers Dis. 2019;71(3):1037-1048. doi: 10.3233/JAD-190264.
5
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.阿尔茨海默病谱系中 tau 和淀粉样蛋白的体内皮质扩散模式。
Ann Neurol. 2016 Aug;80(2):247-58. doi: 10.1002/ana.24711. Epub 2016 Jul 8.
6
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Tau正电子发射断层扫描(PET)模式反映了阿尔茨海默病的临床和神经解剖学变异性。
Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8.
7
Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.小胶质细胞激活和 tau 负担可预测阿尔茨海默病的认知能力下降。
Brain. 2020 May 1;143(5):1588-1602. doi: 10.1093/brain/awaa088.
8
Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease.动态网络模型揭示早发性和晚发性阿尔茨海默病中tau 蛋白的不同传播模式。
Alzheimers Res Ther. 2022 Sep 2;14(1):121. doi: 10.1186/s13195-022-01061-0.
9
Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study.阿尔茨海默病中 tau 蛋白通过功能连接的神经元传播:一项 MEG/PET 联合研究。
Brain. 2023 Oct 3;146(10):4040-4054. doi: 10.1093/brain/awad189.
10
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.早发性和晚发性阿尔茨海默病中不同的 18F-AV-1451 tau PET 保留模式。
Brain. 2017 Sep 1;140(9):2286-2294. doi: 10.1093/brain/awx171.

引用本文的文献

1
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease.在阿尔茨海默病中,tau蛋白病理的半球不对称与淀粉样蛋白沉积的不对称有关。
Nat Commun. 2025 Sep 5;16(1):8232. doi: 10.1038/s41467-025-63564-2.
2
Identifying subtypes of longitudinal motor symptom severity trajectories in early Parkinson's disease patients.识别早期帕金森病患者纵向运动症状严重程度轨迹的亚型。
Front Neurol. 2025 Aug 20;16:1597132. doi: 10.3389/fneur.2025.1597132. eCollection 2025.
3
Spatiotemporal subtypes of brain and spinal cord atrophy in neuromyelitis optica spectrum disorders and multiple sclerosis.

本文引用的文献

1
Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.阿尔茨海默病中选择性易损神经元的分子特征。
Nat Neurosci. 2021 Feb;24(2):276-287. doi: 10.1038/s41593-020-00764-7. Epub 2021 Jan 11.
2
Association of and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.阿尔茨海默病中 Tau 和淀粉样蛋白-PET 的模式与 的关联和临床变异性。
Neurology. 2021 Feb 2;96(5):e650-e661. doi: 10.1212/WNL.0000000000011270. Epub 2020 Dec 1.
3
Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease.
视神经脊髓炎谱系障碍和多发性硬化症中脑和脊髓萎缩的时空亚型。
BMC Med. 2025 Sep 2;23(1):514. doi: 10.1186/s12916-025-04366-7.
4
Towards a multi-organ, multi-omics medical digital twin.迈向多器官、多组学医学数字孪生体。
Nat Biomed Eng. 2025 Aug 25. doi: 10.1038/s41551-025-01474-w.
5
Multiplex nodal modularity: A novel network metric for the regional analysis of amnestic mild cognitive impairment during a working memory binding task.多重节点模块化:一种用于在工作记忆绑定任务期间对遗忘型轻度认知障碍进行区域分析的新型网络指标。
PLoS One. 2025 Aug 22;20(8):e0328736. doi: 10.1371/journal.pone.0328736. eCollection 2025.
6
Multi-organ AI Endophenotypes Chart the Heterogeneity of Pan-disease in the Brain, Eye, and Heart.多器官人工智能内表型描绘大脑、眼睛和心脏中泛疾病的异质性。
medRxiv. 2025 Aug 13:2025.08.09.25333350. doi: 10.1101/2025.08.09.25333350.
7
Neural basis of motor symptoms in Alzheimer's disease: role of regional tau burden and cognition.阿尔茨海默病运动症状的神经基础:区域tau蛋白负荷与认知的作用
Alzheimers Dement. 2025 Aug;21(8):e70598. doi: 10.1002/alz.70598.
8
Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non-human primate models.将神经炎症生物标志物纳入急性肾损伤(X)框架:阿尔茨海默病发病机制、诊断的进展以及非人灵长类动物模型的见解
Alzheimers Dement. 2025 Aug;21(8):e70472. doi: 10.1002/alz.70472.
9
The coming decade of digital brain research: A vision for neuroscience at the intersection of technology and computing.数字脑研究的未来十年:科技与计算交叉领域的神经科学愿景。
Imaging Neurosci (Camb). 2024 Apr 18;2. doi: 10.1162/imag_a_00137. eCollection 2024.
10
Advances in PET imaging of protein aggregates associated with neurodegenerative disease.与神经退行性疾病相关的蛋白质聚集体的正电子发射断层扫描(PET)成像进展。
Nat Rev Neurol. 2025 Aug 11. doi: 10.1038/s41582-025-01126-2.
基于患者中心的连接性预测阿尔茨海默病tau 病理扩散。
Sci Adv. 2020 Nov 27;6(48). doi: 10.1126/sciadv.abd1327. Print 2020 Nov.
4
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.18F-氟托西匹 PET 与阿尔茨海默病和其他神经退行性疾病的尸检比较。
Brain. 2020 Dec 5;143(11):3477-3494. doi: 10.1093/brain/awaa276.
5
Predicting future rates of tau accumulation on PET.预测 PET 上 tau 积聚的未来速率。
Brain. 2020 Oct 1;143(10):3136-3150. doi: 10.1093/brain/awaa248.
6
Cortical developmental abnormalities in logopenic variant primary progressive aphasia with dyslexia.伴有诵读困难的音韵变异型原发性进行性失语中的皮质发育异常。
Brain Commun. 2019;1(1):fcz027. doi: 10.1093/braincomms/fcz027. Epub 2019 Oct 23.
7
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.tau 分子多样性导致阿尔茨海默病的临床异质性。
Nat Med. 2020 Aug;26(8):1256-1263. doi: 10.1038/s41591-020-0938-9. Epub 2020 Jun 22.
8
Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease.病理性 tau 蛋白在人类阿尔茨海默病中通过神经元间的传递而扩散。
Nat Commun. 2020 May 26;11(1):2612. doi: 10.1038/s41467-020-15701-2.
9
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.RO948 F 18 tau 正电子发射断层扫描在阿尔茨海默病与其他神经退行性疾病鉴别诊断中的性能。
JAMA Neurol. 2020 Aug 1;77(8):955-965. doi: 10.1001/jamaneurol.2020.0989.
10
The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study.阿尔茨海默病亚型中的胆碱能系统:一项体内纵向 MRI 研究。
Alzheimers Res Ther. 2020 May 6;12(1):51. doi: 10.1186/s13195-020-00620-7.